Veerhealth Care Ltd (VEERHEALTH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Veerhealth Care Ltd on NSE and BSE, with an AI summary of each filing.
Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Intimation · 14 Nov 2026, 5:30 am
Veerhealth Care Board Meeting Scheduled for 14th Nov'26 to Consider Q2 Results Veerhealth Care Ltd. announced that its Board of Directors will meet on 14th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities, closed since 1st Oct'26, will reopen on 17th Nov'26.
Submission of the transcript of Investors'' call held on 24th October, 2026
Transcript · 28 Oct 2026, 9:57 pm
Veerhealth Care Targets Rs 100 Crore Turnover with Aggressive Capacity Expansion Veerhealth Care is targeting approximately Rs 100 crore in turnover and Rs 5–6 crore PAT for FY26–27, up from Rs 30–33 crore in FY25–26, supported by ~Rs 25 crore revenue in Q1. Contract manufacturing contributed 70% of Q1 revenue, exports 20%, and own brand AYUVEER 10%. The company is expanding production area to 90,000 sq ft, adding 5–6 personal care and 3 oral care lines by Dec'26 to achieve 100% capacity utilization by Q1 FY27-28, supported by US FDA approval and entry into Canadian hospitality supply chains.
Outcome of the investors'' meeting under Reg 30 of LODR held on 24.10.2026
Others · 27 Oct 2026, 9:52 pm
Veerhealth Care Discloses Outcome of Virtual Institutional Investor Group Meeting Veerhealth Care Ltd submitted the outcome of its analyst and institutional investor meeting held on 24th Oct'26. The interaction was conducted as a virtual group meet via Microsoft Teams between 3:00 PM and 3:45 PM, hosting 22 participants, including institutional representatives such as S&P Global. The company confirmed that all discussions were strictly based on publicly available information and no unpublished price sensitive information was shared during the session.
Submission of the link of video recording of investors'' call.
Audio / Video · 27 Oct 2026, 9:32 pm
Veerhealth Care Releases Investor Call Recording and Meeting Outcome Veerhealth Care Ltd. submitted the outcome and recording link of its investors' and analysts' call held virtually on 24th Oct'26 at 3:00 PM. In compliance with Regulation 30 of SEBI LODR Regulations, the company confirmed that discussions were based solely on generally available information and no unpublished price-sensitive information was shared during the meeting. The full recording has been made accessible to stakeholders via the company's official website.
Please find attach herewith intimation of investor call scheduled to be held on 24.10.2026 at 03.00 p.m.
Intimation · 19 Oct 2026, 6:10 pm
Veerhealth Care Schedules Analyst and Institutional Investor Meeting Veerhealth Care Ltd announced that its senior management will host an investor meeting on 24th Oct'26 at 3:00 PM onwards via a virtual platform. The management team will be represented by Managing Director Bhavin S. Shah and Chief Financial Officer Akash Shah. Organized in coordination with AKMIL Strategic Advisors, the interaction will include one-to-one and group discussions with analysts and institutional investors, strictly covering publicly available information.
The Company wishes to inform that it has received an order for supply of skin care products from one of the India''s largest FMCG Company for a value of Rs. 454.68 Lakhs
Others (Uncategorized) · 03 Oct 2026, 6:21 pm
Veerhealth Care Secures Domestic FMCG Order Valued at ₹454.68 Lakhs Veerhealth Care Ltd. has secured a domestic commercial order valued at ₹454.68 Lakhs from a major Indian FMCG company for the supply of face care and skincare products. The contract is scheduled to be executed within a 45-day timeframe. The transaction is not a related-party deal, and promoter entities hold no interest in the awarding client. Management expects this order to drive additional turnover growth.
Please find attached herewith scrutinizers report and voting results for the AGM held on 23rd September 2026
Annual General Meeting · 25 Sept 2026, 4:00 pm
PROCEEDINGS OF THE 34TH ANNUAL GENERAL MEETING HELD TODAY I.E. WEDNESDAY, 23RD SEPTEMBER, 2026
Annual General Meeting · 23 Sept 2026, 11:39 pm
This is in continuation to the notice of 34th Annual general Meeting dated 13/08/2026 which has already been mailed to all the shareholders on 31st August, 2026. A corrigendum is being ....
Annual General Meeting · 22 Sept 2026, 10:31 pm
Please find the attached press release for receipt of order from a Company having Indo-Canadian joint venture for supply of oral care products
Press Release · 11 Sept 2026, 10:23 pm
Veerhealth Care Bags Export Order and Signs Long-Term Supply Agreement Veerhealth Care secured a sample order worth ₹10.07 lakhs and signed an MoU for long-term business with an Indo-Canadian joint venture to supply oral care products across India, USA, and Canada. The client is a major global supplier serving over 15,000 hotels and 20+ airlines. For FY27, Veerhealth projects total income of ₹105 crore and PAT of ₹5–7 crore, including ₹3–4 crore from this client. For FY28, it expects income of ₹156 crore, PAT of ₹9–11 crore, and ₹10 crore from the client.
The Company wishes to inform that it has entered into supply agreement with a Company having an Indo- Canadian joint venture who is one of the world''s largest manufacturers of luxury ....
Others (Uncategorized) · 09 Sept 2026, 10:03 pm
Veerhealth Care Signs Supply Agreement and Bags Rs 10.08 Lakh Oral Care Order Veerhealth Care Ltd has entered into a supply agreement with an Indo-Canadian joint venture—a leading global manufacturer of luxury amenities serving over 15,000 hotels and 20+ airlines across 70+ countries—to manufacture and supply oral care products across India, USA, and Canada. Under this agreement, the company secured its first purchase order for 3,95,000 pieces of oral care products in tubes and sachets valued at Rs 10.08 lakh. The domestic order is slated for execution within 45 days.
Please find the attached press release for the receipt of monthly repeat order worth Rs. 4.36 Crore from one of the India''s leading FMCG Company for supply of skincare products
Press Release · 03 Sept 2026, 9:49 pm
Veerhealth Care Secures ₹4.36 Crore Order and Issues Robust FY27-FY28 Growth Guidance On 3rd Sep'26, Veerhealth Care secured a ₹4.36 crore monthly repeat order for skincare products from a top Indian FMCG player, executable within 45 days. Management issued robust guidance, projecting FY27 total income of ₹105 crores (PAT: ₹5-6 crores) and FY28 income of ₹156 crores (PAT: ₹9-10 crores). Furthermore, the USFDA-cleared manufacturer is in advanced discussions for oral care exports to a major Russian group and finalizing talks with an Indo-Canadian JV for hotel amenities, signaling strong visibility for near-term revenue expansion.
The Company wishes to inform that it has received order from one of the largest FMCG Company for skincare products for a value of Rs. 436.99 Lakhs
Others (Uncategorized) · 03 Sept 2026, 1:08 am
Veerhealth Care Secures Rs. 436.99 Lakh Skincare Order from Major FMCG Company On 2nd Sep'26, Veerhealth Care Ltd. announced securing a domestic order worth Rs. 436.99 Lakhs from a leading, undisclosed Indian FMCG company. The contract for supplying face care products will be executed within a 45-day timeline. Management highlighted this non-related party transaction as a significant opportunity expected to directly drive near-term turnover growth, signaling continued institutional traction and demand for the company's personal care manufacturing capabilities.
Please find the attached herewith the letter sent to shareholders
Others (Uncategorized) · 01 Sept 2026, 2:40 am
Veerhealth Care to Hold 34th Annual General Meeting on 23rd September 2026 Veerhealth Care (BSE: 511523) announced its 34th Annual General Meeting (AGM) will be held via video conference on 23rd Sep'26 at 16:00 IST. The Integrated Annual Report for FY26 has been dispatched via weblink to shareholders who have not registered their email addresses. The company reiterated the requirement for shareholders holding physical securities to update their KYC details, including PAN and bank information, to receive payments electronically, as mandated by SEBI regulations. The cut-off date for shareholder records was 21st Aug'26.
Please find the attached herewith Notice of 34th AGM along with Annual Report for the Financial Year 2025-2026
Annual General Meeting · 01 Sept 2026, 2:36 am
Please find the attached annual report for the financial 2025-2026
Others (Uncategorized) · 01 Sept 2026, 2:30 am
Please find thew attached press release
Press Release · 17 Aug 2026, 2:25 pm
Veerhealth Care Reports Strong Q1FY27, Secures USFDA Clearance and New Orders Veerhealth Care reported strong Q1FY27 results on 14 Aug'26, with revenue up 388.13% YoY to ₹25.09 Cr and PAT up 412.50% YoY to ₹1.23 Cr. EBITDA margin declined 381 BPS to 8.25%. The company secured new orders totaling ₹2244.14 lakhs, including a strategic entry into Sudan. A key highlight is receiving USFDA clearance for its plant, enabling OTC drug exports to the US and positioning it for larger export orders. Management provided FY27 income guidance of ₹105 Cr with PAT of ₹5-6 Cr.
Resignation of Ms. Ashita Chittora as Company Secretary with effect from 13/08/2026
Change in Management · 13 Aug 2026, 10:54 pm
Veerhealth Care Reports Q1FY27 Results and Announces Key Management Changes For Q1FY27 ending 30 Jun'26, Veerhealth Care reported revenue of ₹2,492.56 lakh, a 455% YoY increase. Net profit rose 409% YoY to ₹122.66 lakh, while EPS stood at ₹0.61. Sequentially, revenue grew 48% and the company swung to profit from a loss of ₹35.37 lakh in Q4FY26. The board also announced the resignation of Ms. Ashita Chittora and the immediate appointment of Ms. Ruchi Shah as the new Company Secretary & Compliance Officer, effective 13 Aug'26.
Appointment of Ms. Ruchi Shah(A80942) as company secretary and compliance officer of the Company
Change in Management · 13 Aug 2026, 10:53 pm
Veerhealth Care Q1FY27 Results & Key Management Personnel Changes Veerhealth Care reported a strong Q1FY27 (quarter ended 30-Jun-26) with revenue at ₹2492.56 lakh, up 455.7% YoY, and PAT at ₹122.66 lakh, up 409.8% YoY. Revenue grew 48.6% QoQ while PAT turned positive from a loss of ₹35.37 lakh in Q4FY26. The Board also approved the resignation of Company Secretary (CS) Ms. Ashita Chittora and the immediate appointment of Ms. Ruchi Shah as the new CS and Compliance Officer, effective 13-Aug-26. Ms. Shah is the daughter of Non-Executive Director Mr. Yogesh Shah.
Enclosed herewith the financial results for June, 2026
Financial Result · 13 Aug 2026, 10:48 pm
Veerhealth Care Reports Q1'27 Results and Appoints New Company Secretary Veerhealth Care reported strong Q1'27 results with revenue from operations at ₹2,492.56 lakh, up 455.7% YoY from ₹448.52 lakh. Net profit surged 409.8% YoY to ₹122.66 lakh, compared to ₹24.06 lakh in Q1'26. Sequentially, PAT grew significantly from a loss of ₹35.37 lakh in Q4'26. On 13th Aug'26, the board approved the results, noted the resignation of Company Secretary Ms. Ashita Chittora, and appointed Ms. Ruchi Shah as her replacement. The 34th AGM is scheduled for 23rd Sep'26.
Outcome of the board meeting
Outcome · 13 Aug 2026, 10:45 pm
Veerhealth Care Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 2,493 (+455.7% YoY | +48.7% QoQ) ■ EBITDA: 191 (Loss to Profit YoY | +161.1% QoQ) ■ EBITDA Margin (%): 7.7 (Loss to Profit YoY | +329 bps QoQ) ■ PAT: 123 (+409.8% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.57 (+375.0% YoY | Loss to Profit QoQ)
The Company wishes to inform that it has received an order worth Rs. 5.27 Crores for supply of skincare products and enclosed is the press release of the same
Press Release · 05 Aug 2026, 10:21 pm
Veerhealth Care Secures ₹5.27 Crore Repeat Order From Leading FMCG Player Veerhealth Care secured a monthly repeat order worth ₹5.27 Crores on 05 Aug'26 from a leading Indian FMCG company for its face care products. The order will be executed within 45 days. The company provided forward-looking guidance, expecting FY27 total income of ₹105 crores with PAT of ₹5-6 crores, and FY28 total income of ₹156 crores with PAT of ₹9-10 crores. It also recently received a ₹15.74 lakhs sample order from Sudan, marking its entry into the African market.
Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Intimation · 13 Aug 2026, 5:30 am
The Company wishes to inform about the receipt of order from one of the largest FMCG Company for supply of skincare products for a value of Rs. 526.84 Lakhs
Others (Uncategorized) · 04 Aug 2026, 10:57 pm
Veerhealth Care Secures ₹526.84 Lakhs Skincare Product Order Veerhealth Care Ltd. has secured a significant order valued at ₹526.84 lakhs from a major domestic FMCG company on 04th Aug'26. The contract is for the supply of skincare and face care products and is slated for execution within 45 days. The company anticipates this order will drive additional growth in turnover. The transaction is not with a related party, and the promoter group holds no interest in the entity that awarded the contract.
The Company wishes to announce that it has received a significant Export Order of Rs. 1573992 for supply of Gripe Water from an established buyer based at Sudan
Others (Uncategorized) · 24 Jul 2026, 9:59 pm
Veerhealth Care Secures First Export Order for Gripe Water to Sudan Veerhealth Care Ltd. has secured its first export order, valued at Rs. 15.74 lakhs, for the manufacture and supply of Gripe Water to a buyer in Sudan. Announced on 24th Jul'26, this international contract marks the company's strategic entry into the Sudanese market, expanding its global presence in the pediatric and wellness care segments. The order is slated for execution within 45 days. This move signifies an effort to capitalize on growth opportunities in the African region, with no related party transactions involved.